INTERNATIONAL SOCIETY FOR THE STUDY OF FATTY ACIDS AND LIPIDS (EIN 873756804) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2021

Legal Domicile

Principal Officer

KEVIN LIN

Phone

2024177225

Tax Period

2025-01-01 to 2025-12-31

INTERNATIONAL SOCIETY FOR THE STUDY OF FATTY ACIDS AND LIPIDS, founded in 2021, is a small nonprofit in the Medical Research sector that reported $375K in total revenue in fiscal year 2025. Revenue surged 100% from the prior year, signaling strong growth momentum.

Mission

AN INTERNATIONAL SCIENTIFIC SOCIETY WHOSE MEMBERS CONSIST OF SCIENTISTS, MEDICAL PROFESSIONALS, EDUCATORS, ADMINISTRATORS, COMMUNICATORS AND OTHERS WHO ARE INTERESTED IN INCREASING THE UNDERSTANDING OF THE ROLE OF DIETARY FATTY ACIDS AND LIPIDS IN HEALTH.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $206,889

Program Service Revenue $168,340

Investment Income $24

Other Revenue $0

TOTAL REVENUE $375,253

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $306,861

Other Expenses $407,475

TOTAL EXPENSES $407,475

Year-over-Year Comparison

	2025	2024	Change
Revenue	$375,253	$187,742	+1.0%
Expenses	$407,475	$158,053	+1.6%
Net Income	$-32,222	$29,689	-2.1%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ADINA MICHAEL-TITUS	PRESIDENT	1.00	Officer Director	$0	$0	$0
ANNA NICOLAOU	VICE PRESIDENT	1.00	Officer Director	$0	$0	$0
MARIA MAKRIDES	PAST PRESIDENT	1.00	Director	$0	$0	$0
SVEIN-OLAF HUSTVEDT	SECRETARY	1.00	Officer Director	$0	$0	$0
KEVIN LIN	TREASURER	1.00	Officer Director	$0	$0	$0
MARTIN-PAUL AGBAGA	DIRECTOR	1.00	Director	$0	$0	$0
JEANNINE BAUMGARTNER	DIRECTOR	1.00	Director	$0	$0	$0
CHUCK CHEN	DIRECTOR	1.00	Director	$0	$0	$0
DANIELLE CHRISTIFANO	DIRECTOR	1.00	Director	$0	$0	$0
BERNADETTE DELPLANQUE	DIRECTOR	1.00	Director	$0	$0	$0
JESSICA ELLIS	DIRECTOR	1.00	Director	$0	$0	$0
JACQUELINE GOULD	DIRECTOR	1.00	Director	$0	$0	$0
KEI HAMAZAKI	DIRECTOR	1.00	Director	$0	$0	$0
ANNE-MARIE MINIHANE	DIRECTOR	1.00	Director	$0	$0	$0
SUSAN HAZELS MITMESSER	DIRECTOR	1.00	Director	$0	$0	$0
ADAM METHEREL	DIRECTOR	1.00	Director	$0	$0	$0
HARRY RICE	DIRECTOR	1.00	Director	$0	$0	$0
SAAME SHAIKH	DIRECTOR	1.00	Director	$0	$0	$0
KEN STARK	DIRECTOR	1.00	Director	$0	$0	$0
RACHEL WALKER	DIRECTOR	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$375,253	$407,475	$162,629	$-32,222
2024	No data	No data	No data	No data
2023	$517,472	$466,126	$138,486	$51,346
2022	$186,174	$99,034	$169,592	$87,140

INTERNATIONAL SOCIETY FOR THE STUDY OF FATTY ACIDS AND LIPIDS